27th Annual HeLa
Women's Health Symposium
Shedding Light, Saving Lives: MSM Symposium on Maternal Mortality
Thursday, January 23, 2025 | NCPC Auditorium
9:00 AM – 1:00 PM
#HeLaAtMSM2025
This annual symposium honors Henrietta Lacks, an African American woman with cervical cancer, who in 1951 unknowingly donated her cancer cells when a young resident saved some cells before treatment. She died a few months later, but the first immortal human cell line was developed from her saved cells. Named HeLa, the line has been used extensively in cancer research studies and in the development of vaccines; the polio virus was grown in her cells soon after her death and eventually led to a cure. Use of HeLa has led to important advances such as invitro fertilization, cloning, gene and stem cell research.
We are excited to announce a new maternal health pilot grant -
Make sure you attend to get information about this new program!
Supported by an unrestricted educational grant from:
The Morehouse School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Morehouse School of Medicine designates this live activity for a maximum of up to 3.0 AMA PRA Category 1 credit (s) ™. Physicians should only claim credit commensurate with the extent to their participation in the activity.
At the conclusion of this activity, participants should be able to:
- Evaluate the role of medical racism in shaping systemic barriers to equitable care for vulnerable populations.
- Propose ethical frameworks for healthcare systems to address and eliminate inequities in maternal health outcomes.
- Design patient-centered approaches aimed at improving outcomes for marginalized pregnant individuals.
- Assess how historical exploitation of Black women in medicine has influenced contemporary maternal health inequities.
Morehouse School of Medicine (MSM) in accordance with ACCME guidelines requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by MSM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and the appropriateness of patient care recommendations. Full disclosure of speaker relationships will be made at this activity.
In accordance with the ACCME Standards for Commercial Support of CME, the Morehouse School of Medicine has implemented mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.
This information provided at this CME activity is for continuing education purposes and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.